Answers are grounded in this paper and cite their sources.
BACKGROUND: Cognitive screening tests are essential to the process of early detection and diagnosis of dementia. The Addenbrooke's Cognitive Examination-III (ACE-III) is one such tool. Rater reliability in scoring is an important psychometric property of all tests. AIMS: To investigate rater accuracy in scoring the ACE-III across different raters and by the same raters at two different time points. A secondary exploratory analysis examined whether scoring accuracy is associated with participants' training and experience with the ACE-III. METHODS: A filmed vignette of the ACE-III being administered to an older adult actor (mock patient) was used to assess scoring accuracy across different raters. The vignette had pre-determined "true" scores. Participants were UK National Health Service staff who routinely administer and score the ACE-III as part of their clinical practice. They were asked to view the filmed vignette and complete an ACE-III scoring sheet. After two months, participants scored the same vignette again. RESULTS AND CONCLUSIONS: At Time 1, 20% of participants' scores matched the true score, with 32% deviating by 3-5 points, and an overall range of 10 points. At Time 2, 24% of scores matched the true score, with 11% deviating by three points, and an overall range of six points. Errors were mainly accounted for by the domains requiring subjective judgements, namely the visuospatial and language subtests. Intra-rater consistency was low to moderate. Previous experience of using the ACE-III, nor previous ACE-III training, led to statisically significant differences in scoring performance. Health professionals should consider these findings when scoring the ACE-III and utilize the ACE-III administration and scoring guide to improve accuracy.
No takes yet. Share an insight, caveat, or question.
Thomson et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: